Adrenoleukodystrophy

Endocrine Development

Volumn 20, Issue , 2010, Pages 149-160

  Cappa, Marco ^a   Bizzarri, Carla ^a   Vollono, Catello ^b   Petroni, Anna ^c   Banni, Sebastiano ^d  

^a IRCCS   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; IMMUNOGLOBULIN; LORENZO OIL; VERY LONG CHAIN FATTY ACID;

ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ARTICLE; CORTICOTROPIN BLOOD LEVEL; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; MOLECULAR DIAGNOSIS; NEUROIMAGING; NEUROPATHOLOGY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

ADRENOLEUKODYSTROPHY; ADULT; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HUMANS; MALE;

EID: 78751498730     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000321236     Document Type: Article

References (31)

1. Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW: Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001;49:512.
2. Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, Lopez J, Aubourg P, Mandel JL: The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994;3:265.
3. Kemp S, Wanders RJ: X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007;90:268.
4. Moser HW, Mahmood A, Raymond GV: X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 2007; 3:140.
5. Restuccia D, Di Lazzaro, Valeriani M, Oliviero A, La Pera D, Colosimo C, Burdi N, Cappa M, Bertini E, Di Biase A, Tonali P: Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degree of central nervous system involvement. Brain 1997;120:1139.
6. Steinberg S, Jones R, Tiffany C, Moser A: Investigational methods for peroxisomal disorders. Curr Protoc Hum Genet 2008; chapt 17: unit 17.6.
7. Montagna G, Di Biase A, Cappa M, Melone MA, Piantadosi C, Colabianchi D, Patrono C, Attori L, Cannelli N, Cotrufo R, Salvati S, Santorelli FM: Identification of seven novel mutations in ABCD1 by a DHPLC-based assay in Italian patients with X-linked adrenoleukodystrophy. Hum Mutat 2005; 25:222.
8. X-linked Adrenoleukodystrophy Database [www.x-ald.nl].
9. Wanders RJ, Mooyer PW, Dekker C, Vreken P: X-linked adrenoleukodystrophy: improved prenatal diagnosis using both biochemical and immunological methods. J Inherit Metab Dis 1998;21:285.
10. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P: Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726.
11. Beutler B, Cerami A: The history, properties, and biological effects of cachectin. Biochemistry 1988; 27:7575.
12. Moser HW: Adrenoleukodystrophy: from bedside to molecular biology. J Child Neurol 1987;2:140.
13. Wilichowski E, Ohlenbusch A, Korenke GC, Hunneman DH, Hanefeld F: Identical mitochondrial DNA in monozygotic twins with discordant adrenoleukodystrophy phenotype. Ann Neurol 1998;43:835.
14. Moser H: Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120: 1485.
15. Kobayashi T, Shinnoh N, Kondo A, Yamada T: Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 1997; 232:631.
16. Schaumburg HH, Powers JM, Raine, CS, Suzuki K, Richardson EP Jr: Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 1975;32:577.
17. Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW, Smith KD, Powers JM: Potential environmental and host participants in the early white matter lesion of adrenoleukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 2001;60:1004.
18. Aubourg P, Chaussain JL: Adrenoleukodystrophy: the most frequent genetic cause of Addisons disease. Horm Res 2003;59:104.
19. Cappa M, Cambiaso P, Del Balzo P, Benedetti S, Borrelli P: Hormonal evaluation in adrenoleukodystrophy; in Uziel G, Wandres RJA, Cappa M (eds): Adrenoleukodystrophy and Other Peroxisomal Disorders. Clinical, Biochemical, Genetic and Therapeutic Aspects. Amsterdam, Excerpta Medica, 1990, pp 81-92.
20. Laureti S, Falorni A, Volpato M, Casucci G, Picchio ML, Angeletti G, Luthman H, Brunetti P, Betterle C, Santeusanio F: Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy. Horm Metab Res 1996;28:319.
21. Miike T, Taku K, Tamura T, Ohta J, Ozaki M, Yamamoto C, Sakai T, Antoku Y, Yadomi C: Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy. Brain Dev 1989;11:134.
22. Cappa M, Bertini E, del Balzo P, Cambiaso P, Di Biase A, Salvati S: High dose immunoglobulin IV treatment in adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 1994;57:69.
23. Rizzo WB, Leshner RT, Odone A, Dammann AL, Craft DA, Jensen ME, Jennings SS, Davis S, Jaitly R, Sgro JA: Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 1989;39:1415.
24. Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, Jones RO, Loes DJ, Melhem ER, Dubey P, Bezman L, Brereton NH, Odone A: Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzos oil. Arch Neurol 2005:62: 1073.
25. Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, Grewal SS, Orchard PJ, Abel SL, Goldman AI, Ramsay NKC, Dusenbery KE, Loes DJ, Lockman LA, Kato S, Aubourg PR, Moser HW, Krivit W: Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881.
26. Moser HW, Raymond GV, Dubey P: Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 2005;294:3131.
27. Copelan EA: Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813.
28. Krivit W, Aubourg P, Shapiro E, Peters C: Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 1999;6:377.
29. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, Lockman L, Latchaw RE, Krivit W: Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15: 1761.
30. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrere F, Blanche S, Audit M, Payen E, Leboulch P, lHomme B, Bougneres P, Von Kalle C, Fischer A, Cavazzana-Calvo M, Aubourg P: Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326: 818.
31. Fa M, Diana A, Carta G, Cordeddu L, Melis MP, Murru E, Sogos V, Banni S: Incorporation and metabolism of c9,t11 and t10,c12 conjugated linoleic acid isomers in rat brain. Biochim Biophys Acta 2005;1736:61.